1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,000 | 08:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.03. | Revelation Biosciences GAAP EPS of -$8.33 | 1 | Seeking Alpha | ||
| 22.03. | REVELATION BIOSCIENCES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.03. | Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023 | 159 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained... ► Artikel lesen | |
| 22.03. | REVELATION BIOSCIENCES, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12.03. | REVELATION BIOSCIENCES, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.03. | Revelation Biosciences starts phase 1 trial for Gemini | 1 | Investing.com | ||
| 08.02. | REVELATION BIOSCIENCES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.02. | Why Is Revelation Biosciences (REVB) Stock Down 62% Today? | 5 | InvestorPlace | ||
| 01.02. | Pre-market Movers: Elevai Labs, FibroBiologics, Revelation Biosciences, Bullfrog AI, Nextracker | 514 | AFX News | NORFOLK (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 06.45 A.M. ET).In the Green Elevai Labs, Inc. (ELAB) is up over 94% at $1.32.
FibroBiologics... ► Artikel lesen | |
| 01.02. | Revelation Biosciences to raise ~$6.2M through public offering of shares | 4 | Seeking Alpha | ||
| 31.01. | Pre-market Movers: Guardion Health Sciences, Nuvve Holding, Revelation Biosciences, Pop Culture Group, Paramount Global | 579 | AFX News | SUNNYVALE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.05 A.M. ET).In the Green Guardion Health Sciences, Inc. (GHSI) is up over... ► Artikel lesen | |
| 30.01. | REVELATION BIOSCIENCES, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 29.01. | REVELATION BIOSCIENCES, INC. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 29.01. | Why Is Revelation Biosciences (REVB) Stock Up 61% Today? | 6 | InvestorPlace | ||
| 25.01. | XFRA 56U0: AUSSETZUNG/SUSPENSION | 197 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILREVELATION BIOSC.... ► Artikel lesen | |
| 25.01. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 25.01.2024 | 468 | Xetra Newsboard | The following instruments on XETRA do have their first trading 25.01.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 25.01.2024
Aktien
1 US45773H4092 Inovio Pharmaceuticals... ► Artikel lesen | |
| 24.01. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.01.2024 | 601 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 24.01.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.01.2024ISIN NameCA72583B1094 PIVOTREE... ► Artikel lesen | |
| 24.01. | XFRA ISIN CHANGE | 585 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA1348521024 Nord Precious Metals Mining Inc. 24.01.2024 CA65558V1004 Nord Precious Metals Mining Inc. 25.01.2024 Tausch... ► Artikel lesen | |
| 23.01. | Revelation Biosciences to implement a 1-for-30 reverse split | 2 | Seeking Alpha | ||
| 23.01. | Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024 | 267 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), announced today that, on January 25, 2024, the Company will implement a 1-for-30 reverse... ► Artikel lesen |
Seite:
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TENAX THERAPEUTICS | 3,320 | -100,00 % | Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results | First Patient Enrolled in Phase 3 LEVEL Trial Evaluating TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction (PH-HFpEF)Expansion... ► Artikel lesen | |
| ALTAMIRA THERAPEUTICS | 1,480 | 0,00 % | Altamira Therapeutics Ltd: Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation | Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON... ► Artikel lesen | |
| ARCADIA BIOSCIENCES | 1,970 | +3,68 % | Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights | DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results... ► Artikel lesen | |
| TRACON PHARMACEUTICALS | 1,698 | +3,69 % | TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock Split | SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent Product Development Platform... ► Artikel lesen | |
| ELEVATION ONCOLOGY | 3,510 | 0,00 % | Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements | -- Enrollment ongoing in Phase 1 clinical trial of EO-3021 in the U.S. and Japan; expect to announce initial safety and efficacy data by mid-3Q 2024, with additional data in 1H 2025 --
-- Presented... ► Artikel lesen | |
| ALZAMEND NEURO | 0,535 | -100,00 % | Alzamend Neuro enters private placement of up to $25M | ||
| ARIDIS PHARMACEUTICALS | 0,310 | 0,00 % | Aridis Pharmaceuticals, Inc. - 8-K, Current Report | ||
| KYMERA THERAPEUTICS | 38,610 | 0,00 % | Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript | ||
| BEAM THERAPEUTICS | 22,540 | 0,00 % | Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss | ||
| JANUX THERAPEUTICS | 51,94 | 0,00 % | Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights | SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 8,640 | 0,00 % | Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know | ||
| ARCELLX | 52,73 | 0,00 % | Arcellx Provides First Quarter 2024 Financial Results | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 42,950 | 0,00 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference | ||
| VERA THERAPEUTICS | 42,330 | 0,00 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 1, 2024, the Compensation Committee of Vera's Board of Directors granted inducement... ► Artikel lesen | |
| ADMA BIOLOGICS | 6,930 | 0,00 % | ADMA BIOLOGICS, INC. - 10-Q, Quarterly Report |
REVELATION BIOSCIENCES INC gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,200 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
